Net Income

As CEO Corie Barry prepares for a key UBS conference, investors seek clarity on Best Buy's strategy for growth amid soft sales and a shifting retail landscape.

As Hyperfine preps its 2025 results, investors and clinicians watch to see if its portable Swoop MRI can translate clinical promise into financial success.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

The smart baby monitor firm posts a record $105.7M in 2025 revenue and positive adjusted EBITDA, but a significant net loss raises questions.

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

With a strong cash position, ArriVent pushes its lead lung cancer drug toward a mid-2026 data readout while building a new pipeline in ADCs.

AI deepfakes and WhatsApp groups fueled a massive stock scam that cost investors their life savings. Now, victims are fighting back. Here's how it happened.

New preclinical data shows Quanta Therapeutics' inhibitors remain potent against cancers that have developed resistance to advanced pan-RAS treatments.

El Pollo Loco is testing five bold new menu items. We dive into the strategy, the competition, and what it means for the fast-casual chicken wars.

On its 50th anniversary, NAHQ launches a new ecosystem to arm the healthcare workforce against staff shortages, financial pressures, and digital disruption.

Tel Aviv's stock exchange reports unprecedented 2025 growth, fueled by strategic global outreach, a booming IPO market, and remarkable market resilience.

A new report predicts 3.1 million Ontarians will have a major illness by 2040, revealing regional disparities and straining an already fragile system.

TNS Associates marks its 43rd anniversary with a local ranking, shining a light on Denver's booming estate planning market and modern business awards.

VIO Med Spa is using an advanced training university to standardize excellence, drive rapid franchise growth, and define the future of aesthetic medicine.

Newsweek honors a Bronx facility for its quality care, but the award highlights the complex reality families face when navigating the world of long-term care.

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

Amid a 400% surge in ransomware targeting SAP, Onapsis and partners like Microsoft will tackle the security crisis driven by AI and cloud adoption.

A new multi-year deal gives RNAi leader Alnylam access to Helix's vast genomic and clinical data, aiming to redefine the speed of drug discovery.

February saw 3.8 billion robocalls, a yearly drop. But a rise in daily call rates and massive scam campaigns show the fight is far from over.

A new study reveals ER burnout isn't just from long hours, but from chaotic patient intake. Can an AI co-pilot be the antidote for exhausted clinicians?